Vitamin D3

Catalog No.S4063

Vitamin D3 is a form of vitamin D, binds and activates a H305F/H397Y mutant vitamin D receptor (VDR) with EC50 of 300 nM.

Price Stock Quantity  
In DMSO USD 130 In stock
USD 97 In stock
Bulk Inquiry

Massive Discount Available

Free Overnight Delivery on all orders over $ 500.

Vitamin D3  Chemical Structure

Vitamin D3 Chemical Structure
Molecular Weight: 384.64

Validation & Quality Control


Product Information

  • Combination Therapy
    Combination Therapy

Product Description

Biological Activity

Description Vitamin D3 is a form of vitamin D, binds and activates a H305F/H397Y mutant vitamin D receptor (VDR) with EC50 of 300 nM.
Targets H305F/H397Y mutant vitamin D receptor [1]
IC50 300 nM(Kd)
In vitro Vitamin D3 is a fat-soluble vitamin that helps your body absorb calcium and phosphorus. Vitamin D3, a precursor in the 1α,25- dihydroxyvitamin D3 biosynthetic pathway, which does not activate wild-type hVDR. It binds and activates H305F/H397Y variant hVDR ,with 70 fold activation in compare to wide-type hVDR. [1] Epidemiological studies and work on experimental animals strongly suggest a protective effect of cholecalciferol vitamin D3 (1,25(OH)2D3) against colon cancer and several other cancers. [2]
In vivo With UV-radiation, vitamin D3 is synthesized in the skin from the precursors 7-dehydro-cholesterole and provitamin D3. In the liver, vitamin D3 is transformed to 25-hydroxyvitamin D3. Six cytochrome P450 hydroxylases can exhibit this 25-hydroxylation, with the main enzyme being CYP27A1 (25-hydroxylase). The subsequent step is a 1alpha-hydroxylation by CYP27B1 (1-hydroxylase), which produces the most active form of vitamin D3, 1,25-dihydroxyvitamin-D3. This metabolite is inactivated by a 24-hydroxylation by CYP24 (24-hydro-xylase). Vitamin D3 is used for prevention of mortality in adults. However, Vitamin D3 combines with calcium increased the risk of nephrolithiasis. [3]

Protocol(Only for Reference)

Kinase Assay: [1]

Luciferase and β-galactosidase activity assay HEK293T cells are transfected with pCMXwild-type hVDR, pCMXH305F, pCMXH305Y, and pCMXH305F/H397Y. These plasmids contain the Gal4DBD (GBD) fused to the corresponding VDR ligand binding domain (GBD:LBD fusion under the control of a cytomegalovirus (CMV) promoter). The reporter plasmids are p17*4TATAluc, containing the Renilla luciferase gene under the control of four Gal4 response elements located upstream from a minimal thymidine kinase promoter, and pCMXβgal, a plasmid containing the β-galactosidase gene under the control of the mammalian CMV promoter. The ligands are added to the wells at various concentrations ((0.01 μM– 100 μM) LCA and (0.01 μM– 32 μM) cholecalciferol). Cells are harvested and analyzed for luciferase and β-galactosidase activity. Fold activation is calculated by dividing the value at maximal activation by the value at the no ligand data point.

Cell Assay: [3]

Cell lines MCF-7
Concentrations ~ 100 nM
Incubation Time ~ 96 h
Method Vitamin D receptor (VDR)- positive MCF-7 cells in culture are stimulated with the vitamin D metabolites vitamin D3, 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 for 24, 48, 72 and 96 hours in physiological andsupraphysiological concentrations. The expressions of 25-hydroxylase, 1-hydroxylase and 24-hydroxylase and their changes after stimulation are assessed by real-time PCR.

Animal Study: [2]

Animal Models CYP27B1 (−/−) mice
Formulation solidified agar
Dosages ~10.0 mg/kg
Administration Oral

Conversion of different model animals based on BSA (Value based on data from FDA Draft Guidelines)

SpeciesMouseRatRabbitGuinea pigHamsterDog
Weight (kg)
Body Surface Area (m2)0.0070.0250.
Km factor36128520
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of resveratrol used for a mouse (22.4 mg/kg) to a dose based on the BSA for a rat, multiply 22.4 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for resveratrol of 11.2 mg/kg.

Rat dose (mg/kg) = mouse dose (22.4 mg/kg) ×  mouse Km(3)  = 11.2 mg/kg
rat Km(6)


[1] Ousley AM, et al. J Steroid Biochem Mol Biol, 2011, 125(3-5), 202-210.

[2] Hector D, et al. Archives of Biochemistry and Biophysics, 2011, 505(2), 226–230

view more

Clinical Trial Information( data from, updated on 2015-09-19)

NCT Number Recruitment Conditions Sponsor
Start Date Phases
NCT02537509 Not yet recruiting Atopic Dermatitis Rennes University Hospital October 2015 Phase 2
NCT02537509 Not yet recruiting Atopic Dermatitis Rennes University Hospital October 2015 Phase 2
NCT02532062 Not yet recruiting Deficiency of Vitamin D3|COPD University of Pittsburgh|National Cancer Institute (NCI) September 2015 Phase 2
NCT02452762 Not yet recruiting Hypovitaminosis D Childrens Hospital of Eastern Ontario September 2015 Phase 2
NCT02527668 Recruiting Osteopenia/Osteoporosis DSM Nutritional Products, Inc.|University of Zurich|Tufts  ...more DSM Nutritional Products, Inc.|University of Zurich|Tufts University September 2015 Phase 2

view more

Chemical Information

Molecular Weight (MW) 384.64


CAS No. 67-97-0
Storage 3 years -20℃powder
6 months-80℃in solvent
Synonyms Cholecalciferol
Solubility (25°C) * In vitro DMSO 77 mg/mL (200.18 mM)
Ethanol 77 mg/mL (200.18 mM)
Water <1 mg/mL (<1 mM)
In vivo 30% PEG400/0.5% Tween80/5% propylene glycol 30 mg/mL
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
Chemical Name Cyclohexanol, 3-[(2E)-2-[(1R,3aS,7aR)-1-[(1R)-1,5-dimethylhexyl]octahydro-7a-methyl-4H-inden-4-ylidene]ethylidene]-4-methylene-, (1S,3Z)-

Tech Support & FAQs

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Related Others Products

  • CB-839

    CB-839 is a potent, selective, and orally bioavailable glutaminase inhibitor with IC50 of 24 nM for recombinant human GAC. Phase 1.

  • GKT137831

    GKT137831 is a potent, dual NADPH oxidase NOX1/NOX4 inhibitor with Ki of 110 nM and 140 nM, respectively. Phase 2.

  • LB-100

    LB-100 is a water soluble protein phosphatase 2A (PP2A) inhibitor. Phase 1.

  • Puromycin 2HCl

    Puromycin 2HCl is an aminonucleoside antibiotic, which acts as a protein synthesis inhibitor.

  • Cyclosporin A

    Cyclosporin A is an immunosuppressive agent, binds to the cyclophilin and then inhibits calcineurin with IC50 of 7 nM in a cell-free assay, widely used in organ transplantation to prevent rejection.

  • Cyclophosphamide Monohydrate

    Cyclophosphamide Monohydrate is a nitrogen mustard alkylating agent, it attaches the alkyl group to the guanine base of DNA.

  • Pepstatin A

    Pepstatin A is a potent aspartic protease inhibitor, and also inhibits HIV replication.

  • Ribavirin

    Ribavirin, a synthetic guanosine analogue, possesses a broad spectrum of activity against DNA and RNA viruses.

  • (-)-Epigallocatechin Gallate

    (-)-Epigallocatechin Gallate is the main catechin extraction of green tea, which shows multiple bioactivity.


    BAPTA-AM is a selective, membrane-permeable calcium chelator.

Recently Viewed Items

Tags: buy Vitamin D3 | Vitamin D3 supplier | purchase Vitamin D3 | Vitamin D3 cost | Vitamin D3 manufacturer | order Vitamin D3 | Vitamin D3 distributor
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description
Contact Us